Patents by Inventor Sabine Meyenburg

Sabine Meyenburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
    Patent number: 9168224
    Abstract: Pharmaceutical foam compositions substantially free of ethanol and comprising pimecrolimus in a carrier vehicle comprising a mixture of oily solvents amounting to at least 40% of the total weight of the composition and consisting of: i) hexylene glycol; ii) optionally oleyl alcohol; and iii) dimethylisosorbide and/or medium chain triglycerides; and additionally: iv) when oleyl alcohol is absent, water in an amount of less than 25%; v) at least one consistency agent; vi) at least one preservative; and vii) at least one surfactant/emulgator; and propellant gas for foaming; and optionally further conventional excipients. They are indicated for use in the treatment of various skin, nail and mucosal diseases.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: October 27, 2015
    Assignee: Meda Pharma SARL
    Inventors: Meir Eini, Doron Friedman, Stefan Hirsch, Sabine Meyenburg, Nabila Sekkat, Dov Tamarkin
  • Pimecrolimus Foam Composition Containing Hexylene Glycol, Optionally Oleyl Alcohol, Dimethylisosorbide and/or Medium Chain Triglycerides
    Publication number: 20080181854
    Abstract: Pharmaceutical foam compositions substantially free of ethanol and comprising pimecrolimus in a carrier vehicle comprising a mixture of oily solvents amounting to at least 40% of the total weight of the composition and consisting of: i) hexylene glycol; ii) optionally oleyl alcohol; and iii) dimethylisosorbide and/or medium chain triglycerides; and additionally: iv) when oleyl alcohol is absent, water in an amount of less than 25%; v) at least one consistency agent; vi) at least one preservative; and vii) at least one surfactant/emulgator; and propellant gas for foaming; and optionally further conventional excipients. They are indicated for use in the treatment of various skin, nail and mucosal diseases.
    Type: Application
    Filed: April 7, 2005
    Publication date: July 31, 2008
    Applicant: NOVARTIS AG
    Inventors: Meir Eini, Doron Friedman, Stefan Hirsch, Sabine Meyenburg, Nabila Sekkat, Dov Tamarkin